418 related articles for article (PubMed ID: 11583213)
1. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
[TBL] [Abstract][Full Text] [Related]
2. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
Salgado CD
Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.
Muto CA; Giannetta ET; Durbin LJ; Simonton BM; Farr BM
Infect Control Hosp Epidemiol; 2002 Aug; 23(8):429-35. PubMed ID: 12186207
[TBL] [Abstract][Full Text] [Related]
4. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting.
Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Rodney K; Gedris C; Horowitz HW; Wormser GP
Ann Intern Med; 1999 Aug; 131(4):269-72. PubMed ID: 10454948
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay.
Lloyd-Smith P; Younger J; Lloyd-Smith E; Green H; Leung V; Romney MG
J Hosp Infect; 2013 Sep; 85(1):54-9. PubMed ID: 23920443
[TBL] [Abstract][Full Text] [Related]
6. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
7. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible.
Morris-Downes M; Smyth EG; Moore J; Thomas T; Fitzpatrick F; Walsh J; Caffrey V; Morris A; Foley S; Humphreys H
J Hosp Infect; 2010 Jul; 75(3):228-33. PubMed ID: 20363048
[TBL] [Abstract][Full Text] [Related]
8. [Vancomycin resistant Enterococci (VRE)].
Lesens O
Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
[TBL] [Abstract][Full Text] [Related]
10. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
11. Undetected vancomycin-resistant Enterococcus in surgical intensive care unit patients.
Zuckerman RA; Steele L; Venezia RA; Tobin EH
Infect Control Hosp Epidemiol; 1999 Oct; 20(10):685-6. PubMed ID: 10530646
[TBL] [Abstract][Full Text] [Related]
12. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions.
Lai KK; Kelley AL; Melvin ZS; Belliveau PP; Fontecchio SA
Infect Control Hosp Epidemiol; 1998 Sep; 19(9):647-52. PubMed ID: 9778162
[TBL] [Abstract][Full Text] [Related]
13. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
Olivier CN; Blake RK; Steed LL; Salgado CD
Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.
Schuster F; Graubner UB; Schmid I; Weiss M; Belohradsky BH
Klin Padiatr; 1998; 210(4):261-3. PubMed ID: 9743963
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
16. A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?
Puzniak LA; Gillespie KN; Leet T; Kollef M; Mundy LM
Infect Control Hosp Epidemiol; 2004 May; 25(5):418-24. PubMed ID: 15188849
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-resistant enterococci.
Rubinstein E; Keynan Y
Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.
Jung E; Byun S; Lee H; Moon SY; Lee H
Am J Infect Control; 2014 Oct; 42(10):1062-6. PubMed ID: 25278394
[TBL] [Abstract][Full Text] [Related]
19. Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.
McKinnell JA; Kunz DF; Chamot E; Patel M; Shirley RM; Moser SA; Baddley JW; Pappas PG; Miller LG
Infect Control Hosp Epidemiol; 2012 Jul; 33(7):718-24. PubMed ID: 22669234
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
Yiş R; Aslan S; Cıtak C; Değirmenci S
Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
